Partial Oral Therapy for Osteomyelitis and Endocarditis – Is It Time? by Levy CIMAR | Jan 1, 2019 | Publications
The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility? by Levy CIMAR | Jan 1, 2019 | Publications
One for All, but Not All for One: Social Behavior During Bacterial Diseases by Levy CIMAR | Jan 1, 2019 | Publications
U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016 by Levy CIMAR | Jan 1, 2019 | Publications
Usage Patterns of Carbapenem Antimicrobials in Dogs and Cats at a Veterinary Tertiary Care Hospital by Levy CIMAR | Jan 1, 2019 | Publications
